Mechanical circulatory support for elderly heart failure patients

Butler, Craig; Jugdutt, Bodh
September 2012
Heart Failure Reviews;Sep2012, Vol. 17 Issue 4/5, p663
Academic Journal
End-stage systolic heart failure is an increasingly common problem in elderly patients and is associated with high cost, poor quality of life, and poor outcomes. Mechanical circulatory support is a promising therapy as both a bridge to transplantation and destination therapy. Elderly patients are frequently ineligible for heart transplantation because of their age and comorbidities, and the application of mechanical circulatory support for destination therapy in this population is not well defined. A review of the literature was undertaken to better characterize our experience to date with mechanical circulatory support in older heart failure populations. Mechanical circulatory support is being employed increasingly for destination therapy indications in older patients. The newer continuous flow devices appear to have disproportionate advantage in elderly patients, which has translated into marked improvement in 1- and 2-year survival. The rational implementation of MCS devices in elderly heart failure patients needs to focus on (1) continuous flow devices that appear to have particular benefit in this population, (2) extensive pre-MCS assessment including variables relating to frailty, and (3) intervening before these patients develop cardiogenic shock. More data are needed on the cost-benefit analysis of routine use of CF devices as destination therapy in elderly patients with heart failure.


Related Articles

  • Perioperative management of left ventricular assist devices. Sanjay, O. P. // Annals of Cardiac Anaesthesia;2016 Special Issue, Vol. 19, pS19 

    The use of mechanical circulatory support for patients with severe heart failure is on the rist. The poeoperative, intraoperative and postoperative challenges the anaesthesiologists skills. These are discussed in this review.

  • 437 Hospital readmission rates in out-of-hospital mechanical circulatory support patients justify this treatment option in end-stage heart failure patients. El-Banayosy, A.; Arusoglu, L.; Kizner, L.; Morshuis, M.; Sarnowski, P.; Cobaugh, D.; Koerfer, R. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 3 Issue 1, p108 

    An abstract of the study "Hospital readmission rates in out-of-hospital mechanical circulatory support patients justify this treatment option in end-stage heart failure patients," by A. El-Banayosy and colleagues is presented.

  • LIFETIME CIRCULATORY SUPPORT: AN EVOLVING STRATEGY FOR ADVANCED HEART FAILURE. Westaby, Stephen // Current Medical Literature: Cardiology;2004, Vol. 23 Issue 3, p49 

    The article discusses lifetime circulatory support as an evolving strategy for advanced heart failure. The role of mechanical circulatory support is discussed, as well as research findings related to it. Information on new blood pump technology is presented. The considerations for patient...

  • An Abdominal Left Ventricular Assist Device (ALVAD). Frazier, O. H. // Texas Heart Institute Journal;2004, Vol. 31 Issue 3, p288 

    Focuses on the implantable left ventricular assist device, the HeartMate. Implantation of a circulatory support device developed by doctor Michael DeBakey; Information on the heart transplant in a human being performed by Christiaan Barnard; Challenges to heart transplant; Emergence of...

  • A completed paradigm shift for VADS in advanced HF: The INTERMACS registry at 5 years. Young, James B. // Cardiology Today;Nov2010, Vol. 13 Issue 11, p4 

    This article focuses on the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS), the largest compendium of U.S. Food and Drug Administration (FDA)-approved long-term circulatory assist devices implanted in patients with advanced heart failure.

  • Recent Literature.  // Journal of Palliative Medicine;May2012, Vol. 15 Issue 5, p626 

    The article presents abstracts on medical topics including the use of mechanical circulatory support (MCS) as well as palliative care in the management of patients with end-stage heart failure, how the left ventricular assist devices (LVADs) works in patients with heart failure and the...

  • Cardiac transplantation: who to refer and when. Dar, Owais; Banner, Nicholas R. // British Journal of Hospital Medicine (17508460);May2013, Vol. 74 Issue 5, p258 

    For some patients with advanced heart failure, heart transplantation or mechanical circulatory support may be the only treatment left to improve quality life and survival. The timing of intervention is crucial, as patients should be referred before complications such as pulmonary hypertension,...

  • Total Artificial Heart #296. Wordingham, Sara E.; Kasten, Rachel M.; Swetz, Keith M. // Journal of Palliative Medicine;Nov2015, Vol. 18 Issue 11, p985 

    The article discusses the use of mechanical circulatory support to treat patients with advanced heart failure. Topics covered include the use of left ventricular assist devices (LVAD) in people who should have heart transplant. Also mentioned is the support of medical professionals for the use...

  • Commentary on: Cardiac power index: staging heart failure for mechanical circulatory support. Hall, Sg // Perfusion;Nov2012, Vol. 27 Issue 6, p462 

    The article presents several comments and questions based on the article "Cardiac power index: staging heart failure for mechanical circulatory support," by S. Hall and colleagues. The study compared cardiac power index to other commonly used hemodynamic parameters to validate its usefulness to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics